Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Taps Genologics' LIMS to Support Genomic Services Offerings

Premium

GenoLogics said recently that Personalis has licensed its Clarity laboratory information management system to support its genome services offerings for researchers and clinicians.

In a statement, Christian Haudenschild, Personalis' laboratory director, said that his firm selected Clarity LIMS because it could be deployed internally quickly and also because it allows his lab to meet regulatory requirements. For example, it provides capabilities for things like tracking sample names, reagent lot numbers, and users, he said.

Furthermore, "the capability to create our own data fields and customize what users will see on their respective interfaces is also extremely useful for us," he said.

Financial details about the transaction were not disclosed.

Other Clarity customers include Melbourne, Australia-based Peter MacCallum Cancer Center, which licensed Clarity to support its next-generation and Sanger sequencing workflows (BI 3/15/2013).

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.